OM
Price
$3.21
Change
-$0.06 (-1.83%)
Updated
Sep 11 closing price
Capitalization
60.34M
59 days until earnings call
Intraday BUY SELL Signals
RMD
Price
$218.27
Change
-$1.31 (-0.60%)
Updated
Sep 11 closing price
Capitalization
31.49B
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OM vs RMD

OM vs RMD Comparison Chart in %
View a ticker or compare two or three
VS
OM vs. RMD commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OM is a Hold and RMD is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMD($31.5B) has a higher market cap than OM($60.3M). RMD YTD gains are higher at: -8.641 vs. OM (-13.477). RMD has higher annual earnings (EBITDA): 2.15B vs. OM (-56.31M). RMD has more cash in the bank: 1.47B vs. OM (147M). OM has less debt than RMD: OM (104M) vs RMD (826M). RMD has higher revenues than OM: RMD (5.65B) vs OM (118M).
OMRMDOM / RMD
Capitalization60.3M31.5B0%
EBITDA-56.31M2.15B-3%
Gain YTD-13.477-8.641156%
P/E RatioN/A20.93-
Revenue118M5.65B2%
Total Cash147M1.47B10%
Total Debt104M826M13%
FUNDAMENTALS RATINGS
OM vs RMD: Fundamental Ratings
OM
RMD
OUTLOOK RATING
1..100
5764
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9840
PRICE GROWTH RATING
1..100
6555
P/E GROWTH RATING
1..100
10075
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMD's Valuation (14) in the Medical Specialties industry is in the same range as OM (18) in the null industry. This means that RMD’s stock grew similarly to OM’s over the last 12 months.

RMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as OM (100) in the null industry. This means that RMD’s stock grew similarly to OM’s over the last 12 months.

RMD's SMR Rating (40) in the Medical Specialties industry is somewhat better than the same rating for OM (98) in the null industry. This means that RMD’s stock grew somewhat faster than OM’s over the last 12 months.

RMD's Price Growth Rating (55) in the Medical Specialties industry is in the same range as OM (65) in the null industry. This means that RMD’s stock grew similarly to OM’s over the last 12 months.

RMD's P/E Growth Rating (75) in the Medical Specialties industry is in the same range as OM (100) in the null industry. This means that RMD’s stock grew similarly to OM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OMRMD
RSI
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
59%
Advances
ODDS (%)
N/A
Bullish Trend 16 days ago
56%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
62%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (OM: $3.21 vs. RMD: $218.27)
Brand notoriety: OM and RMD are both not notable
OM represents the Medical/Nursing Services, while RMD is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: OM: 68% vs. RMD: 62%
Market capitalization -- OM: $60.34M vs. RMD: $31.49B
OM [@Medical/Nursing Services] is valued at $60.34M. RMD’s [@Pharmaceuticals: Other] market capitalization is $31.49B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $1.86K to $176.41B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $130.41B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.46B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OM’s FA Score shows that 1 FA rating(s) are green while RMD’s FA Score has 1 green FA rating(s).

  • OM’s FA Score: 1 green, 4 red.
  • RMD’s FA Score: 1 green, 4 red.
According to our system of comparison, RMD is a better buy in the long-term than OM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OM’s TA Score shows that 4 TA indicator(s) are bullish while RMD’s TA Score has 4 bullish TA indicator(s).

  • OM’s TA Score: 4 bullish, 6 bearish.
  • RMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RMD is a better buy in the short-term than OM.

Price Growth

OM (@Medical/Nursing Services) experienced а -10.58% price change this week, while RMD (@Pharmaceuticals: Other) price change was -4.41% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.51%. For the same industry, the average monthly price growth was -3.46%, and the average quarterly price growth was +12.67%.

Reported Earning Dates

OM is expected to report earnings on Nov 10, 2026.

RMD is expected to report earnings on Oct 22, 2026.

Industries' Descriptions

@Medical/Nursing Services (-5.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
OM
Daily Signal:
Gain/Loss:
RMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAPOX117.58N/A
N/A
Mairs & Power Balanced
ETAHX55.70N/A
N/A
Eventide Healthcare & Life Sciences A
TRLHX28.03N/A
N/A
Nuveen Large Cap Value I
LHCSX23.54N/A
N/A
Lord Abbett Health Care R4
LFMGX28.77N/A
N/A
Lord Abbett Micro Cap Growth F

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with COO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then COO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
-0.60%
COO - RMD
48%
Loosely correlated
-0.48%
BAX - RMD
48%
Loosely correlated
-1.57%
BDX - RMD
47%
Loosely correlated
+0.81%
SOLV - RMD
44%
Loosely correlated
-0.23%
ISRG - RMD
42%
Loosely correlated
+2.41%
More